Identification of Effective Anticancer G-Quadruplex-Targeting Chemotypes through the Exploration of a High Diversity Library of Natural Compounds.
G-quadruplex
G4-CPG assay
cancer
chelidonine
high diversity library
molecular dynamics
natural compounds
rotenone
telomere
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
03 Oct 2021
03 Oct 2021
Historique:
received:
13
08
2021
revised:
21
09
2021
accepted:
26
09
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
In the quest for selective G-quadruplex (G4)-targeting chemotypes, natural compounds have been thus far poorly explored, though representing appealing candidates due to the high structural diversity of their scaffolds. In this regard, a unique high diversity in-house library composed of ca. one thousand individual natural products was investigated. The combination of molecular docking-based virtual screening and the G4-CPG experimental screening assay proved to be useful to quickly and effectively identify-out of many natural compounds-five hit binders of telomeric and oncogenic G4s, i.e., Bulbocapnine, Chelidonine, Ibogaine, Rotenone and Vomicine. Biophysical studies unambiguously demonstrated the selective interaction of these compounds with G4s compared to duplex DNA. The rationale behind the G4 selective recognition was suggested by molecular dynamics simulations. Indeed, the selected ligands proved to specifically interact with G4 structures due to peculiar interaction patterns, while they were unable to firmly bind to a DNA duplex. From biological assays, Chelidonine and Rotenone emerged as the most active compounds of the series against cancer cells, also showing good selectivity over normal cells. Notably, the anticancer activity correlated well with the ability of the two compounds to target telomeric G4s.
Identifiants
pubmed: 34683905
pii: pharmaceutics13101611
doi: 10.3390/pharmaceutics13101611
pmc: PMC8537501
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG2020 n. 25046 to D.M.
Références
Nucleic Acids Res. 2007;35(15):4927-40
pubmed: 17626043
Nat Prod Rep. 2020 Jul 1;37(7):893-918
pubmed: 32186299
J Chem Inf Model. 2017 Sep 25;57(9):2099-2111
pubmed: 28853576
Nature. 2007 Aug 30;448(7157):1068-71
pubmed: 17687332
J Am Chem Soc. 2008 Nov 26;130(47):15758-9
pubmed: 18975896
Int J Biol Macromol. 2021 Jan 1;166:1320-1334
pubmed: 33166559
Clin Cancer Res. 2020 Jul 1;26(13):3408-3419
pubmed: 32156748
J Am Chem Soc. 2020 Oct 7;142(40):16999-17014
pubmed: 32915558
Molecules. 2020 Aug 09;25(16):
pubmed: 32784887
J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Int J Mol Sci. 2021 Mar 06;22(5):
pubmed: 33800884
ACS Med Chem Lett. 2019 Feb 26;10(4):639-643
pubmed: 30996810
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Histol Histopathol. 2003 Apr;18(2):541-50
pubmed: 12647805
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188410
pubmed: 32827579
ChemMedChem. 2018 Mar 6;13(5):406-410
pubmed: 29345419
J Biomol NMR. 2003 Aug;26(4):297-315
pubmed: 12815257
Biochim Biophys Acta Gen Subj. 2017 Nov;1861(11 Pt A):2843-2851
pubmed: 28780124
Top Curr Chem. 2013;330:211-42
pubmed: 22851158
Biochemistry. 2005 Feb 15;44(6):2048-58
pubmed: 15697230
J Chem Theory Comput. 2016 Aug 9;12(8):4114-27
pubmed: 27300587
Trends Chem. 2020 Feb;2(2):123-136
pubmed: 32923997
Antibiotics (Basel). 2020 Jun 13;9(6):
pubmed: 32545761
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Trends Mol Med. 2020 Sep;26(9):848-861
pubmed: 32467069
Nucleic Acids Res. 2020 Dec 2;48(21):12380-12393
pubmed: 33170272
Nat Rev Drug Discov. 2011 Apr;10(4):261-75
pubmed: 21455236
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Chem Inf Model. 2005 May-Jun;45(3):542-8
pubmed: 15921444
ACS Med Chem Lett. 2020 Jan 30;11(5):760-765
pubmed: 32435382
J Chem Theory Comput. 2015 Dec 8;11(12):5723-36
pubmed: 26588601
Nature. 2013 Feb 28;494(7438):502-5
pubmed: 23389450
Nucleic Acids Res. 2009 Apr;37(6):1713-25
pubmed: 19190094
J Med Chem. 2021 Apr 8;64(7):3578-3603
pubmed: 33751881
Int J Mol Sci. 2020 Mar 13;21(6):
pubmed: 32183038
Bioorg Med Chem. 2008 Mar 15;16(6):3025-31
pubmed: 18191403
Phytochemistry. 2020 Dec;180:112530
pubmed: 33049649
J Org Chem. 2020 Aug 21;85(16):10891-10901
pubmed: 32806095
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
In Vivo. 2008 May-Jun;22(3):305-9
pubmed: 18610740
Int J Mol Med. 2020 Aug;46(2):700-708
pubmed: 32626924
Nat Rev Mol Cell Biol. 2020 Aug;21(8):459-474
pubmed: 32313204
J Chem Theory Comput. 2012 Sep 11;8(9):3314-21
pubmed: 26605738
Sci Rep. 2017 May 19;7(1):2213
pubmed: 28526832
J Exp Clin Cancer Res. 2014 Oct 06;33:81
pubmed: 25288403
EXCLI J. 2018 May 04;17:420-451
pubmed: 29805348
Cancers (Basel). 2019 Oct 09;11(10):
pubmed: 31601026
J Chem Inf Model. 2020 Dec 28;60(12):6555-6565
pubmed: 33138374
Molecules. 2012 Mar 09;17(3):3025-43
pubmed: 22406905
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):2020-2030
pubmed: 28479277
J Nat Prod. 2020 Jun 26;83(6):1829-1845
pubmed: 32459967
Nat Commun. 2017 Feb 17;8:14432
pubmed: 28211448
Eur J Med Chem. 2019 Feb 1;163:295-306
pubmed: 30529547
Chemistry. 2021 Jun 16;27(34):8832-8845
pubmed: 33890349
EMBO J. 2015 Jan 13;34(2):200-17
pubmed: 25476449
Cell. 1998 Feb 6;92(3):401-13
pubmed: 9476899
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1341-1352
pubmed: 28130159
Front Genet. 2019 Apr 30;10:368
pubmed: 31114606
Anal Chim Acta. 2018 Nov 7;1030:133-141
pubmed: 30032762
J Antimicrob Chemother. 2020 Sep 1;75(9):2564-2572
pubmed: 32514531
Angew Chem Int Ed Engl. 2018 Jun 11;57(24):7171-7175
pubmed: 29076232
Nat Prod Rep. 2019 Jul 1;36(7):942-943
pubmed: 31250867
Int J Biol Macromol. 2020 May 15;151:1163-1172
pubmed: 31747572
J Med Chem. 2016 Jul 14;59(13):5987-6011
pubmed: 26840940
Alkaloids Chem Biol. 2001;56:1-38
pubmed: 11705103
Sci Rep. 2015 Jun 16;5:11385
pubmed: 26077929